about
The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in SepsisClinical Criteria for a Pathogen in Term Newborn Suspected of Neonatal SepsisIdentification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of SepsisVitamin A Status in Critically Ill Children With Sepsis and Its Association With Illness SeverityAssessment of qSOFA in the Latin America Sepsis Institute DatabaseAdrenal Cortical Function and Vitamin A Deficiency in SepsisSafety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal SepsisAcute Phase Proteins as Early Markers in SepsisClinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe SepsisEfficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory FailureSepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular CoagulationMethylene Blue in Sepsis: A Randomized Controlled TrialPharmacokinetic of Ceftriaxone in Septic ICU PatientsThe Utility of Ischemia Modified Albumin (IMA) in SepsisClinical Trial of the Optimal Endpoint of Early Sepsis ResuscitationHydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe SepsisMild Therapeutic Hypothermia During Severe SepsisComparing an Automated to a Conventional Sepsis Clinical Prediction RuleAssociation Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han PopulationThe Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of SepsisMiRNAs Evaluate the Prognosis of Sepsis by Dynamic StudyEmergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis TrialMaternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for CesareanEvaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.Simplified Severe Sepsis Protocol in ZambiaPreemptive Resuscitation for Eradication of Septic ShockPrognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of SepsisAngiotensin II Antagonist in Severe SepsisUtility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis SyndromeThe AVERT Sepsis InvestigationLactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?A Study in Sepsis Patients With Renal FailureProtocolized Care for Early Septic ShockCirculating microRNAs as Biomarkers of SepsisNeonatal Sepsis and GBS Carriage StudyImplementation and Evaluations of Sepsis WatchImpact of Sleep Apnea on Sepsis MortalitySubpopulation-Specific Sepsis Identification Using Machine LearningnSeP: Detecting Neonatal Sepsis by Immune-Metabolic Network Analysis
P1050
Q61894402-0FAEF846-DC9C-49A7-8E61-A4B3E4A5E588Q61902388-14ECC9AE-DAB8-41E8-B9CB-232AB99C39B7Q61902689-D3C7454D-6716-4007-A713-2C259A150E48Q61907929-78A526AD-1292-47D7-AC25-DBD8204003C6Q61909426-5B6AB41C-5D2C-43CF-8C85-9186E3A59400Q61909905-29980A73-FFA0-4E8F-9558-008C2B26F5C1Q61914346-F23A3C5B-3361-4B3D-8F9A-1D3919063DF3Q61914833-889D2116-4D61-42D6-81B4-EA4E63C7EA3FQ61915547-8CF32C23-6E37-46AB-AF84-F2C080875975Q61915598-3C3DA126-F23A-4A1F-A72B-159AA5D5ADD8Q61918193-C6ECA3D0-11D3-488F-868C-AA391CACDA64Q61918308-A88D108F-C9EB-4810-8697-46F5817BA31BQ61918449-D51CF8B9-82E2-4A6F-9D22-1C2E390445F4Q61921131-AE019461-0DAD-466F-B694-84500FA7F5BEQ61923102-D9FACE90-F293-4DE0-B4FA-A5167E9A3037Q61932975-4A115B42-9AA1-45A6-B41E-CE5D661395A2Q61933728-785E27F6-C303-4C9A-A41C-9FA5BC609C01Q61938961-7AA9C5AA-CEE1-4B98-9F17-64265018F61AQ61957103-3ED02CD0-214F-4283-BBE8-5F2694F5A1CDQ61957283-9A5D9217-493B-48D0-BCDE-0DA94AA3D65DQ61957614-BB9742C9-BEE9-424D-BE94-EF09BEEDEB41Q61965753-106D548D-1DAA-4027-9802-8DC8C3EE53E2Q61966927-B8353CC9-8E9C-4CBD-8800-206989179EEFQ61967316-DD35FC90-E1CA-43A5-A1D3-E6F10690FCB5Q61967437-695BAEA8-FDE3-4F57-A23A-A844D136634BQ61967511-57ACCDE2-C936-4FEC-8BC9-46876541806BQ61967544-2EA85DAF-C9E2-4012-A266-75941683993FQ61969686-43A16757-69C1-468B-AFEE-164047C850CAQ61969909-3D083B9F-D0A7-4F14-8CE7-3BA94D422C82Q61969966-584753FF-C4E8-4B58-A691-455FEEF6A75BQ61975490-8CA5C627-478E-4D13-9B88-67DF94546947Q61975822-5EED49F5-7D8C-4607-A1DB-62C87990CA3EQ61979135-132DABE8-0261-4D84-9A36-394EE4E872D8Q61979162-9CB243A8-A687-4F90-8453-14B5E5DDD72DQ61981332-F60CB553-4E96-4913-A4CE-E626A56E5112Q61981442-D0E0DC0F-FC88-4159-BD5A-8CD17E4CD88FQ62024961-EA02EBCD-927A-4D68-B386-12E45B9FF91FQ62025083-E1F1D4B5-1748-477C-8EEB-42079B4FBA46Q62025866-0E7D498A-3E67-42AD-87C5-1FF048922BE1Q62030725-B8D3395D-08A2-48A5-BC09-8664DCC0805F
P1050
description
presence of toxins or other harmful substances in the blood
@en
presencia de toxinas u otras sustancias dañinas en la sangre
@es
name
toxemia
@en
toxemia
@es
toxémie
@fr
type
label
toxemia
@en
toxemia
@es
toxémie
@fr
prefLabel
toxemia
@en
toxemia
@es
toxémie
@fr
P486
P672
P1995
P31
P486
P672
C01.539.861